By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PolyPid Ltd. 

13 Hamazmera Street

Ness-Ziona     74047  Israel
Phone: +972-74-7037457 Fax: n/a


Medical Device

Drug Delivery

Company News
PolyPid Ltd. Completes Enrollment In Phase Ib/II Study Of D-PLEX In Post-Cardiac Surgery Sternal Infection 8/16/2017 6:31:53 AM
PolyPid Ltd. Announces Positive Interim Data From Company's Confirmatory Clinical Trial For BonyPid-1000 Antibiotic Eluting Bone Substitute 3/9/2017 7:06:11 AM
PolyPid Ltd. Announces Receipt Of Qualified Infectious Disease Product (QIDP) Designation From FDA For D-PLEX In Post-Cardiac Surgery Sternal Infection 3/8/2017 7:17:13 AM
PolyPid Ltd. Announces Completion Of $22 Million Series D Financing 2/24/2016 7:30:01 AM
PolyPid Ltd. Announces First Patient Enrolled In Confirmatory Clinical Trial, Evaluating Performance And Safety Of BonyPid-1000, An Antibiotic Eluting Bone Void Filler 12/2/2015 6:54:40 AM
PolyPid Ltd. Announces Issuance Of New U.S. Patent For Doxycycline Sustained Release Compositions 11/19/2015 11:31:04 AM
Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues 3/27/2015 8:03:07 AM
Bone Biotech PolyPid Ltd. Files For A $24 Million IPO 10/16/2014 6:31:22 AM
PolyPid Ltd. Announces U.S. Patent Allowance For Sustained Release Of Nucleic Acid Matrix Compositions 7/7/2014 10:51:58 AM
PolyPid Ltd. and MIS Implants Technologies Announce Strategic Partnership to Provide Innovative Drug Delivery Product for Dental Applications 3/4/2013 12:03:27 PM